Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Inhibition of human immunodeficiency virus type 1 transcription by N-aminoimidazole derivatives — Miguel Stevens (2007) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Inhibition of human immunodeficiency virus type 1 transcription by N-aminoimidazole derivatives
Shared by
De Clercq Erik
KU Leuven
Inhibition of human immunodeficiency virus type 1 transcription by N-aminoimidazole derivatives
Article
2007
en
Authors
+6 more
MS
Miguel Stevens
JB
Jan Balzarini
IL
Irene M. Lagoja
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2002
Inhibition of Human Immunodeficiency Virus Type 1 Integration by Diketo Derivatives
Wim Pluymers
,
Godwin C. G. Pais
,
Bénédicte Van Maele
,
Christophe Pannecouque
,
Valery Fikkert
,
Terrence R. Burke
,
De Clercq Erik
,
Myriam Witvrouw
,
Nouri Neamati
,
Zeger Debyser
Article
1999
Inhibition of Human Immunodeficiency Virus Type (HIV-1) Replication by some Diversely Functionalized Spirocyclopropyl Derivatives
Myriam Witvrouw
,
Christophe Pannecouque
,
De Clercq Erik
,
E. FERNANDEZ‐ALVAREZ
,
José L. Marco
Article
1992
Kinetics of Inhibition of Endogenous Human Immunodeficiency Virus Type 1 Reverse Transcription by 2',3'-Dideoxynucleoside 5'-
Zeger DebyserS
,
Anne‐Mieke Vandamme
,
Rudi Pauwels
,
Masanori BabaO
,
Jan Desmyter
,
De Clercq Erik
Article
1999
ChemInform Abstract: Inhibition of Human Immunodeficiency Virus Type (HIV‐1) Replication by Some Diversely Functionalized Spirocyclopropyl Derivatives.
Myriam Witvrouw
,
Christophe Pannecouque
,
De Clercq Erik
,
E. FERNANDEZ‐ALVAREZ
,
José L. Marco
Article
1991
Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives.
Masanori Baba
,
De Clercq Erik
,
H. TANAKA
,
Masaru Ubasawa
,
Hideaki Takashima
,
Kouichi Sekiya
,
Issei Nitta
,
Kohei Umezu
,
Roland Walker
,
S Mori
Discussion(0)
No comments yet. Be the first to comment.